trending Market Intelligence /marketintelligence/en/news-insights/trending/FMdCDb66A_41Xq5uT2cpUA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Raymond James downgrades Carolina Financial Corp. on deal

Key Credit Risk Factors When Assessing Banks In The Context Of COVID-19

Street Talk Episode 61 - Investors debate if U.S. banks have enough capital in post COVID world

You Down With PPP? Consider The Risks

Street Talk Episode 60 - You Down With PPP? Consider The Risks

Raymond James downgrades Carolina Financial Corp. on deal


Raymond James analyst William Wallace downgraded Charleston, S.C.-based Carolina Financial Corp. to "market perform" from "strong buy" based on its announced agreement to be acquired by Charleston, W.Va.-based United Bankshares Inc.

United Bankshares' rating is "market perform," according to the analysts' note. "We expect [Carolina Financial] shares will trade in line with [United Bankshares] shares until the deal closes," Wallace wrote. "As such, we are downgrading ... to align with our rating on [United Bankshares.]"

The analyst estimated earnings per share of $3.00 for 2019 and 2020 and did not provide a new price target.


Keefe Bruyette & Woods analysts Christopher O'Connell, Collyn Gilbert and Rob Dowers initiated coverage of Elmira, N.Y.-based Chemung Financial Corp. with a rating of "market perform."

Despite low interest rates and "intense competition," the analysts believe Chemung is "well positioned to combat these headwinds," due to its optimized balance sheet, consistent fee income growth and limited expense growth.

Chemung has "significant opportunity to optimize its low-cost deposit base," the analysts wrote in a note, "which should result in higher earnings."

The analysts initiated coverage with a price target of $49 and EPS estimates of $3.32 for 2019, $3.80 for 2020, and $3.82 for 2021.